Treace Medical Concepts (TMCI)
(Real Time Quote from BATS)
$5.67 USD
+0.20 (3.66%)
Updated Aug 7, 2025 12:48 PM ET
3-Hold of 5 3
D Value A Growth B Momentum B VGM
Fundamental Charts
About Market Cap
As of the previous market close, Treace Medical Concepts, Inc. has a market cap of $344.01M, which represents its share price of $5.47 multiplied by its outstanding shares number of 62.89M. As a small-cap company, TMCI's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
TMCI 5.67 +0.20(3.66%)
Will TMCI be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TMCI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TMCI
Tactile Systems Technology (TCMD) Surpasses Q2 Earnings and Revenue Estimates
Wall Street Analysts See a 41.11% Upside in Treace Medical Concepts (TMCI): Can the Stock Really Move This High?
TMCI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Treace Medical Concepts (TMCI) Reports Q1 Loss, Tops Revenue Estimates
Veracyte (VCYT) Q1 Earnings and Revenues Beat Estimates
Orthofix (OFIX) Reports Q1 Loss, Tops Revenue Estimates
Other News for TMCI
Treace Medical management to meet virtually with Lake Street
Treace Medical (TMCI) Reports Promising ALIGN3D Study Outcomes
Treace Medical publishes four-year interim results from ALIGN3D study
Zimmer Biomet sued for violating Treace Medical patents related to bunion treatment